Experimental evidence for human mitochondrial DNA (mtDNA) recombination was recently obtained in an individual with paternal inheritance of mtDNA 1 and in an in vitro cell culture system 2 . Whether mtDNA recombination is a common event in humans remained to be determined. To detect mtDNA recombination in human skeletal muscle, we analyzed the distribution of alleles in individuals with multiple mtDNA heteroplasmy using single-cell PCR and allele-specific PCR. In all ten individuals who carried a heteroplasmic D-loop mutation and a distantly located tRNA point mutation or a large deletion, we observed a mixture of four allelic combinations (tetraplasmy), a hallmark of recombination. Twelve of 14 individuals with closely located heteroplasmic D-loop mutation pairs contained a mixture of only three types of mitochondrial genomes (triplasmy), consistent with the absence of recombination between adjacent markers. These findings indicate that mtDNA recombination is common in human skeletal muscle.
Experimental evidence for human mitochondrial DNA (mtDNA) recombination was recently obtained in an individual with paternal inheritance of mtDNA 1 and in an in vitro cell culture system 2 . Whether mtDNA recombination is a common event in humans remained to be determined. To detect mtDNA recombination in human skeletal muscle, we analyzed the distribution of alleles in individuals with multiple mtDNA heteroplasmy using single-cell PCR and allele-specific PCR. In all ten individuals who carried a heteroplasmic D-loop mutation and a distantly located tRNA point mutation or a large deletion, we observed a mixture of four allelic combinations (tetraplasmy), a hallmark of recombination. Twelve of 14 individuals with closely located heteroplasmic D-loop mutation pairs contained a mixture of only three types of mitochondrial genomes (triplasmy), consistent with the absence of recombination between adjacent markers. These findings indicate that mtDNA recombination is common in human skeletal muscle.
It is not known for certain whether intermolecular heterologous recombination of mtDNA, which occurs in plants, fungi, protists, certain mussels and some fish 3 , also occurs in humans [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Experimental evidence for mtDNA recombination was recently obtained in an individual with paternal inheritance of mtDNA 1 and in an in vitro cell culture system obtained by fusion of two human cybrid cell lines 2 (also see ref. 15 ). Owing to the specific and rare features of the individual case 1, 16 (no other cases of paternal inheritance of mtDNA have been reported so far 17, 18 ), further work is required to determine the in vivo impact of human mtDNA recombination.
To detect mtDNA recombination in human skeletal muscle, we analyzed the distribution of allelic combinations in individuals with multiple mtDNA heteroplasmy (i.e., individuals carrying a mixture of wild-type and mutated sequences at more than one location in their mitochondrial genome). If the main source of this mtDNA heteroplasmy is clonal expansion of early developmental mutations 19 , then two single de novo mutational events would be sufficient to generate double heteroplasmy. In the absence of mtDNA recombination, mutants originally generated on different mtDNA molecules would remain separated, and only three types of mtDNA molecules (triplasmy) would be expected: the original wild-type (W 1 W 2 ) and molecules with one (M 1 W 2 ) or the other (W 1 M 2 ) position mutated. In contrast, a mtDNA crossover between these two positions would lead to a fourth (mixed) genotype with a second mutation on the already mutated DNA copy. As a result, all four possible allelic combinations (tetraplasmy) would be present in the tissue: the wildtype (W 1 W 2 ), two single mutants (M 1 W 2 and W 1 M 2 ) and the double mutant (M 1 M 2 ). In some cases, however, heteroplasmy may result from recurrent mutation of the same nucleotide position on different DNA molecules. Obviously, recurrent mutations will also result in tetraplasmy. Therefore, the analysis of allelic combinations in individuals with multiple mtDNA heteroplasmy allows one to demonstrate recombination if the possibility of recurrent mutation can be excluded.
We identified ten individuals carrying heteroplasmic pathogenic mtDNA mutations in the coding region and one additional heteroplasmic D-loop mutation at np71, np72 or np16297 or two additional heteroplasmic D-loop mutations at np185 and np189. In these individuals, we determined the corresponding allelic distributions of mutations. All ten individuals showed a tetraplasmic distribution of all coding region mtDNA mutations with respect to distantly located D-loop mutations ( Table 1 and Figs. 1 and 2) . By allele-specific PCR analysis of samples from individuals p1-p5 and p7-p10, both alleles of the corresponding D-loop mutation were always detectable after allele-specific amplification of the coding-region mutant or wild-type mtDNA. PCR generates artificial recombinants by template-totemplate jumping 20 . To exclude this artifact, we subjected control triplasmic mixtures (t1 and t2), each consisting of three of four possible allelic combinations of double mutations, to the same procedures. As expected, the controls remained triplasmic throughout the procedure (Fig. 1b,e) .
We carried out two additional experiments to exclude the possibility of PCR artifacts in our system. First, for individuals p1 and p10 who carry deleted mtDNA, we separated the deleted and wild-type molecules by high-resolution agarose gel electrophoresis before carrying out PCR. In this setting, the DNA species potentially subject to artificial recombination are separated before PCR. We then investigated the putative presence of tetraplasmy by restriction analysis. Tetraplasmy was confirmed (Fig. 2) , and the distribution of the four allelic combinations was (within experimental error) identical to that obtained using allele-specific PCR (Supplementary Table 1 online).
In the second experiment, we carried out single-fiber genotype analysis. This approach is based on the fact that point mutations in mtDNA are frequently subject to intracellular clonal expansions 21 , which result in homoplasmic fibers with almost pure mitochondrial genotype. To confirm tetraplasmy, it is sufficient to detect homoplasmic fibers carrying each of the four genotype combinations in a pure form. We analyzed allelic combinations in M, point mutation; t1 and t2, triplasmic controls; U, undigested PCR product for control; W, wild-type. (a) The 16297C mutant-specific restriction digestion product (filled arrowhead) is present in both deleted and wild-type mitochondrial genomes in individual p1. Because 16297T is also present in both deleted and wild-type mtDNA (not shown), the sample is tetraplasmic. The absence of the deletion-specific band (empty arrowhead) in lane W confirms excellent specificity of the wild-type-specific PCR. (b) del71 mutation-specific and 71G wild-type-specific bands are present both in the wild-type and in the del12103-14411-specific PCR products from individual p2. In the triplasmic control (t1), only the three input allelic combinations are detectable. t1 is a mixture of the wild-type (72T) and single mutants 72C and del8426-14138, used to imitate the mutations in individual p2. 
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single muscle fibers for individuals p3 (Fig. 1f,g ), p4 and p6 and identified fibers with almost pure (W 1 W 2 , M 1 W 2 , W 1 M 2 and M 1 M 2 ) genotypes. All four genotypes were present in muscle; therefore, the tissue is tetraplasmic. As long as PCR artifacts are excluded (Supplementary Note online), two mechanisms might be responsible for tetraplasmy: recurrence of the mutations or mtDNA recombination. Because pathogenic mutations are rare in the general population, recurrence of these mutations is highly unlikely. To evaluate the probability of recurrence of D-loop mutations, we relied on the frequency of the heteroplasmic state of these mutations in our collection of more than 300 skeletal muscle and brain DNA samples (Supplementary Table 2 online). Our data indicate a very low statistical likelihood for recurrence of the T16297C and the del71 D-loop mutations (we detected each mutation in only one of all screened skeletal muscle and brain samples, respectively). The sites at np72, np185 and np189 were more frequently observed in the heteroplasmic state, indicating a higher probability of a recurrent mutation.
To evaluate directly the probability of recurrent D-loop mutations, we investigated allelic combinations in individuals with heteroplasmic D-loop mutations at adjacent loci, which are unlikely to recombine 1, 4 . We identified seven individuals with A185G/A189G double heteroplasmy in skeletal muscle (individuals p3, p4 and p11-p15) and six individuals with A185G/A189G double heteroplasmy in the brain. In another individual (individual p16), we detected A185G/ins195A double heteroplasmy in skeletal muscle. As expected, for the mutation pairs A185G/A189G (Fig. 3a,c) and A185G/ins195A (Fig. 3b) , we observed a mixture of three types of mitochondrial genomes (triplasmy) in six of eight skeletal muscle samples and in six of six brain samples (data not shown). In accordance with previous work 22 on a single individual with A185G/A189G heteroplasmy, this indicates that double heteroplasmy was largely created by clonal expansion of only two single de novo mutational events in most (12 of 14) of the individuals with A185G/A189G and A185G/ ins195A heteroplasmy that we investigated. Because mtDNA recombination is unlikely to cause the tetraplasmy observed in individuals p13 and p15 (Fig. 3a) owing to the close location of sites 1,4 , a low incidence of recurrence of the A185G/A189G mutations has to be considered. This is in line with the higher frequency of A185G and A189G heteroplasmy in comparison to the T16297C, del71 and T72C mutations observed in skeletal muscle and brain tissue (Supplementary Table 2 online). Therefore, it is extremely improbable that tetraplasmy in the ten individuals with coding-region mtDNA mutations (Table 1) might be caused by recurrence of D-loop mutations. In this context, individuals p3 and p4 who carry three heteroplasmic mutations (A3243G, A185G, A189G) show triplasmy (no recombination) between the close sites at np185 and np189 (Fig. 3a,c) but tetraplasmy (indicating recombination) between the distant sites at np3243 and np185 or np189, respectively ( Fig. 1d-g ). Taken together, these data indicate that only mtDNA recombination events can explain the observed tetraplasmic distribution pattern of alleles. This interpretation seems to contrast with previous reports [23] [24] [25] that did not detect mtDNA recombinants in certain individuals with mtDNA diseases. Possible reasons for this discrepancy include the segregational loss of one allele (e.g., by selection) and the low frequency of allelic recombination (e.g., limited contact between heterologous molecules). For the individuals we report here, we cannot determine which are the 'native' molecules and which are the recombinant ones, because the history of the evolution of native alleles in each individual's muscle is unknown. We estimate the minimum fraction of recombinants (i.e., the fraction of the least represented allelic combination) to be between 0.3% and 16% ( Table 1) . This minimum fraction is highly variable among individuals and should be interpreted with Figure 2 Tetraplasmic distribution of alleles is confirmed using pre-PCR separation by gel electrophoresis, which is not subject to PCR artifacts. PvuII-digested total muscle DNA samples from two individuals (p10 and p1) carrying large-scale deletions were subjected to high-resolution agarose gel electrophoresis to separate the wild-type and deleted mtDNA molecules. Mutation loads of D-loop mutations (72C in individual p10 and 16297C in individual p1) were determined independently in both the wild-type (W) and deleted (D) electrophoretic fractions by PCR and restriction digestion (Supplementary Table 1 online). The purity of individual fractions was confirmed by multiplex PCR ( Supplementary Fig. 3 online) . Fourth lane from left, 25-bp DNA ladder. B, bulk muscle; c1, homoplasmic 16297T control.
caution. Mutations used as recombination markers and hence recombinants themselves were subject to global clonal expansions in muscle of these individuals. Therefore, the fraction of recombinants may reflect the efficiency of clonal expansion rather than the intrinsic recombination rate. Taken together, our data indicate the presence of mtDNA recombination events in skeletal muscle of ten individuals. Therefore, mtDNA recombination in humans is not limited to a single exceptional individual 1, 16 . This observation is highly relevant to the mechanisms of progression and expression of mtDNA disorders and should be considered for future gene therapeutic strategies. Our observations are of interest for the evolutionary studies of human mtDNA, though they are limited to a somatic tissue.
METHODS
Subjects and controls. The individuals with mtDNA mutations in the coding region whom we investigated are listed in Supplementary Table 3 online. We isolated control muscle DNA samples from skeletal muscle biopsies of individuals with neurological disorders. We obtained brain samples from surgical material removed during epilepsy surgery. The study was done in accordance with the guidelines of the University of Bonn Ethical Commission, and informed consent was obtained from all subjects. mtDNA mutation analysis. We extracted genomic DNA from 30-mg skeletal muscle specimens with the QiaAmp DNA Mini Kit (Qiagen). We quantified large-scale deletions by Southern blotting of PvuII-linearized genomic DNA using digoxigenin-labeled isolated human mtDNA as full-length mtDNA probe. We excluded the presence of duplications by digestion with PmeI or BamHI. We visualized the individual bands by chemiluminescence (DIG Luminescent Detection Kit; Boehringer Mannheim), quantified them by densitometry and corrected values for the length difference. We amplified the PCR products specific for deleted or nondeleted mitochondrial genomes and encompassing polymorphic D-loop sites by using a D-loop primer together with primers located inside the deletion region (for wild-type product), outside the deletion close to the far end breakpoint (for deletion product) or between the deletion and the D-loop (for total amount). A detailed list of primers used in specific cases is given in Supplementary Table 4 online, and a schematic representation of positions of mutations and used PCR primers is shown in Supplementary Figure 1 online. Amplification conditions were as follows: 95 1C for 2 min and 30 s; 35 cycles of 92 1C for 25 s and 68 1C for 4 min; and finally 72 1C for 7 min. To detect the T16297C polymorphism, we digested PCR products with MseI restriction endonuclease. We carried out double digestion with restriction endonucleases SphI and BanII to quantify the amounts of the T72C polymorphism. SphI served to detect the 72C allele, and BanII provided digestion fragments for the estimation of the total amount of the PCR product. We separated restriction fragments on 10% polyacrylamide gels and visualized them by SYBR Green I staining (Sigma-Aldrich). We estimated proportions of wild-type and mutant mitochondrial DNA from band intensities using the Image J analysis software. We tested the putative effects of heteroduplex formation on mutant quantification in control experiments ( Supplementary  Fig. 2 online) .
For the A3243G MELAS mutation, we used allele-specific primers together with a D-loop primer (Supplementary Table 4 online) to amplify long PCR products. To increase allele specificity, the allele-specific primers contained a mismatch nucleotide. The number of amplification cycles was restricted to 20. We then used an aliquot of the long PCR products as a template in a second round of mismatch PCR. We used a similar two-round PCR method for the del12103-14411/del71 case and to examine distribution of D-loop polymorphisms between alleles of the A185G polymorphic site.
We used mismatch primers (Supplementary Table 4 online) to generate an appropriate site for restriction fragment length polymorphism (RFLP) analysis if a natural site was not available. To detect the 185G and 189G alleles in PCR products, we used Cac8I restriction endonuclease. We quantified the del71 allele by BslI digestion, the 72C allele by BglI digestion and the ins195A polymorphism by NsiI digestion. We detected the new pathogenic G5835A mutation by digesting mismatch PCR products with BanII endonuclease.
We determined the allelic distributions for double heteroplasmies in two steps. First, we determined the mutant load for the first mutation of the two. For example, for individual p1, we determined the load of deletion (52%) by Southern-blot analysis of total DNA. We then subjected DNA to two allele-specific PCRs, each of which amplified either wild-type or the mutant molecules with respect to the first mutation (e.g., the deletion and the wild type for individual p1). We then subjected each of the two PCR products to RFLP analysis to determine the load of the second mutation. For individual p1, the load of T16297C in the deletion-specific PCR was 56% (Supplementary Table 1 online and data not shown); hence, the load of the deletion/16297C genotype (M 1 M 2 in Table 1 ) is 0.52 Â 0.56 ¼ 0.29. We directly sequenced PCR products on an automatic sequence analyzer (ABI 377, Applied Biosystems).
Single-fiber PCR analysis. We placed 10-mm frozen sections of skeletal muscle on slides with poly-L-lysine-treated polyethylene naphthalate membrane and immersed them sequentially in 70% ethanol, 95% ethanol, absolute ethanol and xylene. We cut single fibers from air-dried samples using the P.A.L.M. MicroBeam system operating with a nitrogen laser (P.A.L.M.) and catapulted them to a tube cap containing 20 ml of magnesium-free PCR buffer, 10Â diluted Tris-EDTA buffer and 0.5% Tween 20. After a short centrifugation and incubation for 1 h at room temperature, samples were divided into two to three aliquots and directly subjected to mismatch PCR and RFLP analysis.
High resolution agarose gel electrophoresis. We linearized total DNA isolated from muscle tissue with PvuII. We loaded 2 mg of DNA on 0.8% agarose gels and subjected them to electrophoresis at 1 V cm À1 for 48 h. We excised the bands of interest from the gel, extracted DNA using a QIAEX II gel extraction kit (Qiagen) and subjected it to PCR.
